Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT05726019
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 100 participants
- Registry
-
NCT05726019
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Brazil
- Registry status
- Completed
Technical summary
Registry record NCT05726019. Randomized; single masking; primary purpose prevention. Start 2022-02-05 (actual); primary completion 2025-12-21 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome
- Acronym
- COCAR
- Condition
- Coronary Artery Disease
- Condition
- Acute Coronary Syndrome
- Condition
- Coronary Artery Bypass
- Condition
- Myocardial Reperfusion
- Condition
- Postpericardiotomy Syndrome
- Condition
- Postoperative Atrial Fibrilation
- Condition
- Perioperative Myocardial Infarction
- Intervention (Drug)
- Colchicine
- Lead sponsor
- University of Sao Paulo General Hospital
Record details
- Record id
cardio:ct-nct05726019- Content hash
2b2c9d084b0acb3c4ed1cebf1c461d9094fdad6f2662e131c3eeb6be56f33e1a